# A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

> **NCT04056455** · PHASE1 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Renal Impairment
- Healthy Volunteers

## Interventions

- **DRUG:** Mobocertinib

## Key facts

- **NCT ID:** NCT04056455
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-04
- **Primary completion:** 2022-04-20
- **Final completion:** 2022-04-20
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056455, "A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04056455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*